ARTICLE | Clinical News
Modiodal modafinil regulatory update
December 5, 2011 8:00 AM UTC
Mitsubishi and Alfresa said Japan approved Modiodal modafinil for excessive diurnal sleepiness accompanied by obstructive sleep apnea (OSA) syndrome in patients under treatment for airway obstruction ...